Published in Br J Obstet Gynaecol on December 01, 1997
Validation of Bladder Health Instrument for Evaluation in Women (VIEW) | NCT04016298
One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires. Int Urogynecol J (2015) 1.97
Evaluation and outcome measures in the treatment of female urinary stress incontinence: International Urogynecological Association (IUGA) guidelines for research and clinical practice. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.95
P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2004) 1.61
Lower urinary tract symptoms in women with benign joint hypermobility syndrome: a case-control study. Int Urogynecol J (2013) 1.44
Questionnaires for women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.36
Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse? Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.29
Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J (2012) 1.25
Women's experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups. Neurourol Urodyn (2011) 1.18
A validated self-administered female pelvic floor questionnaire. Int Urogynecol J (2009) 1.14
The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.10
Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes (2005) 1.09
Factors predictive of post-TVT voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.04
Measuring outcomes in urogynecological surgery: "perspective is everything". Int Urogynecol J (2012) 1.03
A review of solifenacin in the treatment of urinary incontinence. Ther Clin Risk Manag (2008) 0.98
Assessment of sexual function in women with pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.97
Distress and quality of life characteristics associated with seeking surgical treatment for stress urinary incontinence. Health Qual Life Outcomes (2009) 0.95
Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.95
Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.94
Effect of prolapse repair on voiding and the relationship to overactive bladder and detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.93
Transvaginal polypropylene mesh versus sacrospinous ligament fixation for the treatment of uterine prolapse: 1-year follow-up of a randomized controlled trial. Int Urogynecol J (2010) 0.92
Validity and reliability of the Turkish version of the Pelvic Floor Distress Inventory-20. Int Urogynecol J (2012) 0.92
A Systematic Review of Quality of Life Measures in Pregnant and Postpartum Mothers. Appl Res Qual Life (2013) 0.92
Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training. BJU Int (2013) 0.92
Efficacy and safety of TVT-O and TVT-Secur in the treatment of female stress urinary incontinence: 1-year follow-up. Int Urogynecol J (2010) 0.92
Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.91
Content validation of the patient-reported outcomes measurement information system (PROMIS) framework in women with urinary incontinence. Neurourol Urodyn (2011) 0.90
The minimum important difference for the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire. Int Urogynecol J (2014) 0.90
Quality assurance in quality of life assessment--measuring the validity of the King's Health Questionnaire. Int Urogynecol J (2014) 0.89
A study of quality of life in primigravidae with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.89
Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.89
Validation of a global pelvic floor symptom bother questionnaire. Int Urogynecol J (2010) 0.88
Urethral hypermobility after anti-incontinence surgery - a prognostic indicator? Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.88
Anorectal, bladder, and sexual function in females following colorectal surgery for carcinoma. Int J Colorectal Dis (2008) 0.88
How urgent is urgency? A review of current methods of assessment. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.88
Funneling before and after anti-incontinence surgery--a prognostic indicator? Part 2: tension-free vaginal tape. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.88
Effects of carrying a pregnancy and of method of delivery on urinary incontinence: a prospective cohort study. BMC Pregnancy Childbirth (2004) 0.88
Reliability and validity of the Turkish King's Health Questionnaire in women with urinary incontinence. Int Urogynecol J (2015) 0.88
Role of fesoterodine in the treatment of overactive bladder. Open Access J Urol (2009) 0.87
Urogenital function following laparoscopic and open rectal cancer resection: a comparative study. Surg Endosc (2012) 0.87
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo. Health Qual Life Outcomes (2009) 0.85
Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.85
Female sexual function after transobturator tape in women with urodynamic stress urinary incontinence. Springerplus (2014) 0.85
Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.85
Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure? Int Urogynecol J (2011) 0.85
The Michigan Incontinence Symptom Index (M-ISI): a clinical measure for type, severity, and bother related to urinary incontinence. Neurourol Urodyn (2013) 0.85
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence. Int Urogynecol J (2014) 0.85
Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study. Int J Clin Pract (2008) 0.84
Comparison of voiding questionnaires between female interstitial cystitis and female idiopathic overactive bladder. Int Neurourol J (2010) 0.84
Adaptation and validation of the King's Health Questionnaire in Portuguese women with urinary incontinence. Int Urogynecol J (2015) 0.84
The effects of duloxetine on urethral function and sphincter morphology. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.83
Prevalence of faecal incontinence among women with urinary incontinence. Br J Obstet Gynaecol (1999) 0.83
Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J (2012) 0.82
Impact of stress urinary incontinence and overactive bladder on micturition patterns and health-related quality of life. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.82
How accurate is symptomatic and clinical evaluation of prolapse prior to surgical repair? Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.82
Do we need meshes in pelvic floor reconstruction? World J Urol (2011) 0.82
Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: why do tapes fail? Int Urogynecol J (2013) 0.82
The Incontinence Outcome Questionnaire: an instrument for assessing patient-reported outcomes after surgery for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.81
Randomized controlled trial of pelvic floor muscle training with or without biofeedback for urinary incontinence. Int Urogynecol J (2013) 0.81
Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model. BMC Urol (2011) 0.81
Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial. World J Urol (2004) 0.81
The impact of TVT on sexual function. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.81
The effect of urethral dilatation on pressure flow studies in women with voiding dysfunction and overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.81
New onset stress urinary incontinence following laparoscopic sacrocolpopexy and its relation to anatomical outcomes. Int Urogynecol J (2015) 0.80
Non-fistulous urinary leakage among women attending a Nigerian family planning clinic. Int J Womens Health (2011) 0.80
The value of vaginal packing in pelvic floor surgery: a randomised double-blind study. Int Urogynecol J (2013) 0.80
Sexual activity and lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.80
Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation. Int Urogynecol J (2012) 0.80
Anatomical outcome and quality of life following posterior vaginal wall prolapse repair using collagen xenograft. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.80
Recent advances. Gynaecology. BMJ (1999) 0.80
Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.80
Outcome measures in urogynaecology: the clinicians' perspective. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.80
Validation, reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL) in a Brazilian population. Int Urogynecol J (2011) 0.80
Shortcomings/strengths of specific sexual function questionnaires currently used in urogynecology: a literature review. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.79
Behavioral Intervention Program versus Vaginal Cones on Stress Urinary Incontinence and Related Quality of Life: A Randomized Clinical Trial. Oman Med J (2014) 0.79
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module. Health Qual Life Outcomes (2014) 0.79
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions. Int J Clin Pract (2007) 0.79
Selecting a medical therapy for overactive bladder. Rev Urol (2002) 0.78
Health-related quality of life. The effect of pelvic floor muscle training and midurethral sling surgery: a systematic review. Int Urogynecol J (2012) 0.78
Predicting detrusor overactivity using a physician-based scoring system. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.78
The influence of an overactive bladder on falling: a study of females aged 40 and older in the community. Int Neurourol J (2011) 0.78
Can sex survive pelvic floor surgery? Int Urogynecol J (2010) 0.78
Cost-effectiveness of an Internet-based treatment program for stress urinary incontinence. Neurourol Urodyn (2013) 0.78
Validation of the Polish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire. Int Urogynecol J (2015) 0.78
The fibromyalgia bladder index. Clin Rheumatol (2007) 0.78
Psychosomatic Aspects of Urinary Incontinence in Women. Geburtshilfe Frauenheilkd (2015) 0.78
Fesoterodine for the treatment of urinary incontinence and overactive bladder. Ther Clin Risk Manag (2009) 0.78
Clinical validation of the Bladder Health Survey for urinary incontinence in a population sample of women. Int Urogynecol J (2015) 0.78
Patient and surgeon goal achievement 10 years following surgery for pelvic organ prolapse and urinary incontinence. Int Urogynecol J (2015) 0.78
Quality of life in multiple sclerosis patients with urinary disorders: reliability and validity of the Turkish version of King's Health Questionnaire. Neurol Sci (2011) 0.78
Validation of Persian version of the Prolapse Quality-of-Life questionnaire (P-QOL). Int Urogynecol J (2011) 0.77
Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study. World J Urol (2013) 0.77
A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol (1998) 0.77
Bladder outlet obstruction after pubovaginal fascial sling. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.77
Lower urinary tract disease: what are we trying to treat and in whom? Br J Pharmacol (2006) 0.77
Internet-based treatment of stress urinary incontinence: 1- and 2-year results of a randomized controlled trial with a focus on pelvic floor muscle training. BJU Int (2015) 0.77
Impact of episiotomy on pelvic floor disorders and their influence on women's wellness after the sixth month postpartum: a retrospective study. BMC Womens Health (2011) 0.77
Perspectives on overactive bladder in the elderly population. World J Urol (2009) 0.77
Pathophysiology of sexual dysfunction as related to pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.77
A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol (1997) 2.26
Impact of mode of delivery on levator morphology: a prospective observational study with three-dimensional ultrasound early in the postpartum period. BJOG (2011) 2.22
Rectal distension: the effect on bladder function. Neurourol Urodyn (2011) 2.08
Effect of vaginal ultrasound probe on lower urinary tract function. Br J Urol (1992) 2.04
Evaluating ambulatory urodynamics: a prospective study in asymptomatic women. BJOG (2001) 1.91
A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol (1994) 1.69
Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract (2013) 1.55
Prolonged pregnancy: is induction of labour indicated? A prospective study. Br J Obstet Gynaecol (1982) 1.54
A cost-effectiveness analysis of delayed sphincteroplasty for anal sphincter injury. Colorectal Dis (2008) 1.51
The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study. Br J Obstet Gynaecol (1990) 1.48
Denervation and re-innervation of the urethral sphincter in the aetiology of genuine stress incontinence: an electromyographic study. Br J Obstet Gynaecol (1993) 1.47
Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol (1997) 1.46
Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet (1984) 1.30
Imaging the urethral sphincter with three-dimensional ultrasound. Obstet Gynecol (1999) 1.20
Pelvic organ prolapse and overactive bladder. Neurourol Urodyn (2010) 1.17
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod (2004) 1.16
A comparison of vaginal and suprapubic surgery in the correction of incontience due to urethral sphincter incompetence. Br J Urol (1979) 1.14
Idiopathic bladder instability treated by biofeedback. Br J Urol (1978) 1.14
Prevalence and risk factors for urinary incontinence in Italy. Eur Urol (2000) 1.13
Should we abandon Kielland's forceps? Br Med J (Clin Res Ed) (1983) 1.12
Evaluation of flurbiprofen in detrusor instability. Br Med J (1980) 1.10
The pharmacological treatment of urinary incontinence. BJU Int (1999) 1.06
Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract (2013) 1.03
Obstetric characteristics in different racial groups. Br J Obstet Gynaecol (1983) 1.02
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol (2001) 1.01
Surgical treatment of incontinence in elderly women. Surg Gynecol Obstet (1980) 1.01
Morbidity after ambulatory urodynamics. Neurourol Urodyn (2002) 1.00
Detrusor instability following surgery for genuine stress incontinence. Br J Urol (1979) 0.97
Effects of domperidone on QTc interval in infants. Acta Paediatr (2012) 0.97
Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence. Neurourol Urodyn (2009) 0.97
Quality of life and urinary incontinence. Curr Opin Obstet Gynecol (1995) 0.96
Urological complications of traumatic diastasis of the symphysis pubis in the female. Br J Urol (1981) 0.95
Standardisation of ambulatory urodynamic monitoring: Report of the Standardisation Sub-Committee of the International Continence Society for Ambulatory Urodynamic Studies. Neurourol Urodyn (2000) 0.95
Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol (1997) 0.94
Ultrasound: a noninvasive screening test for detrusor instability. Br J Obstet Gynaecol (1996) 0.94
Probiotics in infectious diarrhoea in children: are they indicated? Eur J Pediatr (2007) 0.93
Genuine stress incontinence and detrusor instability--a review of 200 patients. Br J Obstet Gynaecol (1980) 0.92
Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Eur J Neurol (2011) 0.91
Predictive value of cervimetric labour patterns in primigravidae. Br J Obstet Gynaecol (1982) 0.89
Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome. Neurourol Urodyn (2010) 0.89
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease. Neurogastroenterol Motil (2012) 0.87
Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int (2001) 0.86
Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. Int Urogynecol J (2013) 0.85
Endothelin-1 plasma concentrations in patients with retinitis pigmentosa. Regul Pept (2009) 0.85
Videocystourethrography with a ring pessary in situ. A clinically useful preoperative investigation for continent women with urogenital prolapse? Int Urogynecol J Pelvic Floor Dysfunct (1998) 0.85
The effects of pregnancy on previous incontinence surgery. Case report. Br J Obstet Gynaecol (1991) 0.84
Results of the colposuspension operation for incontinence and prolapse. Br J Obstet Gynaecol (1979) 0.84
A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol (1980) 0.84
Perineal pad weighing versus videographic analysis in genuine stress incontinence. Br J Obstet Gynaecol (1986) 0.84
Reducing artefacts in ambulatory urodynamics. Br J Urol (1998) 0.83
Three-dimensional ultrasound: a novel technique for investigating the urethral sphincter in the third trimester of pregnancy. Ultrasound Obstet Gynecol (2001) 0.83
Internal urinary sphincter in maintenance of female continence. Br Med J (Clin Res Ed) (1986) 0.82
Prevalence and significance of urethral instability in women with detrusor instability. Br J Urol (1993) 0.82
Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art. Eur Rev Med Pharmacol Sci (2014) 0.82
The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. Curr Urol Rep (2012) 0.82
Outcome of spontaneous labour in multigravidae. Br J Obstet Gynaecol (1982) 0.82
Assessment of urinary symptoms in early pregnancy. Br J Obstet Gynaecol (1991) 0.81
Variability of the 13C-acetate breath test for gastric emptying of liquids in healthy children. J Pediatr Gastroenterol Nutr (2006) 0.81
Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue. Hum Genet (1992) 0.80
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice. Eur J Neurol (2014) 0.80
A comparison of the objective and subjective outcomes of colposuspension for stress incontinence in women. BJOG (2001) 0.79
Current pharmacological treatment of gastroparesis. Expert Opin Pharmacother (2004) 0.79
GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow up. Br J Obstet Gynaecol (1997) 0.79
An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability. J Urol (1979) 0.78
The total antioxidant capacity of the diet is an independent predictor of plasma beta-carotene. Eur J Clin Nutr (2006) 0.78
Hair zinc levels in infants. Clin Pediatr (Phila) (1983) 0.78
Treatment of delayed onset of spontaneous voiding after surgery for incontinence. Urology (1979) 0.78
Air transport pilot involvement in general aviation accidents. Ergonomics (1986) 0.77
Biofeedback: a 5-year review. Br J Urol (1984) 0.77
Social and obstetric features associated with smoking in pregnancy. Br J Obstet Gynaecol (1982) 0.77
Variability of the 13C-octanoic acid breath test for gastric emptying of solids in healthy children. Aliment Pharmacol Ther (2006) 0.77
Direct imaging of the pelvic floor muscles using two-dimensional ultrasound: a comparison of women with urogenital prolapse versus controls. BJOG (2007) 0.77
Pharmacological management of detrusor instability. Int Urogynecol J Pelvic Floor Dysfunct (2001) 0.76
Oxybutynin topical and transdermal formulations: an update. Drugs Today (Barc) (2010) 0.76
Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia. Eur J Haematol Suppl (1990) 0.76
Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography. Acta Obstet Gynecol Scand (1995) 0.76
A comparison study of two lower urinary tract symptoms screening tools in clinical practice: the B-SAQ and OAB-V8 questionnaires. J Obstet Gynaecol (2012) 0.75
The pubofascial anchor sling procedure for recurrent genuine urinary stress incontinence. BJU Int (2000) 0.75
Urinary incontinence. BMJ (1992) 0.75
Outcome of breech delivery at term. BMJ (1992) 0.75
Impact of surgery for stress incontinence on morbidity. Effects of confounding variables on outcomes of incontinence surgery must be considered. BMJ (1998) 0.75
Impact of surgery for stress incontinence on the social lives of women. Br J Obstet Gynaecol (1999) 0.75
Conservative management of genuine stress incontinence in women. Study's flaws may be misleading. BMJ (1999) 0.75
Urinary urgency in women. Br J Hosp Med (1993) 0.75
Infectious morbidity in gynecologic oncologic surgery. A clinical and economic evaluation. Clin Exp Obstet Gynecol (1993) 0.75
Re: "The pelvic floor muscles: muscle thickness in healthy and urinary-incontinent women measured by perineal ultrasonography with reference to the effect of pelvic floor training. Estrogen receptor studies." Neurourol. Urodynam. 1997;16:237-275. Neurourol Urodyn (1999) 0.75
Cesarean section: an economic appraisal of infectious complications. Clin Exp Obstet Gynecol (1993) 0.75
[Evaluation of a new method for cervical cytology]. Minerva Ginecol (1992) 0.75
[Infectious complications in oncologic-gynecologic surgery: clinical and economic evaluation]. Minerva Ginecol (1993) 0.75
Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study. Eur Rev Med Pharmacol Sci (2016) 0.75
A comparison of bioelectrical and mechanical activity of the female urethra. Br J Obstet Gynaecol (1993) 0.75